30th week of 2019 patent applcation highlights part 23 |
Patent application number | Title | Published |
20190225579 | TREATMENT OF FABRY DISEASE | 2019-07-25 |
20190225580 | PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE | 2019-07-25 |
20190225581 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | 2019-07-25 |
20190225582 | METHOD FOR PREPARING PHENYLALANINE COMPOUND | 2019-07-25 |
20190225583 | CARBAZOLE DERIVATIVES | 2019-07-25 |
20190225584 | LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF | 2019-07-25 |
20190225585 | METHOD OF PRODUCING FLUORINE-CONTAINING PYRAZOLE CARBOXYLIC ACID HALIDE | 2019-07-25 |
20190225586 | PROCESS FOR PREPARING 3-FLUOROALKYL-5-PYRAZOLECARBOXYLATES AND 3-FLUOROALKYL-5-PYRAZOLECARBOXYLIC ACIDS | 2019-07-25 |
20190225587 | INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES | 2019-07-25 |
20190225588 | Compositions for the Treatment of Hypertension and/or Fibrosis | 2019-07-25 |
20190225589 | TRIAZOLE CONJUGATED UREAS, THIOUREAS, CARBAMATES, AND REVERSED CARBAMATES FOR PSMA-TARGETED IMAGING AGENTS AND USES THEREOF | 2019-07-25 |
20190225590 | METHOD FOR PREPARING FLUOROALKYLNITRILES AND THE CORRESPONDING FLUOROALKYLTETRAZOLES | 2019-07-25 |
20190225591 | PROCESS FOR PREPARING 5-PHENOXY-1(3)ISOBENZOFURANONE | 2019-07-25 |
20190225592 | ANTI-INFECTIVE AGENTS | 2019-07-25 |
20190225593 | SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME | 2019-07-25 |
20190225594 | Herbicidal Pyrimidine Compounds | 2019-07-25 |
20190225595 | TUBULIN INHIBITOR | 2019-07-25 |
20190225596 | Cannabinergic Nitrate Esters And Related Analogs | 2019-07-25 |
20190225597 | PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2019-07-25 |
20190225598 | NOVEL CHEMOKINE CXCR1 AND CXCR2 RECEPTOR ANTAGONIST COMPOUNDS, AND USE THEREOF IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES | 2019-07-25 |
20190225599 | RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF | 2019-07-25 |
20190225600 | BENZOFURAN PYRAZOLE AMINE KINASE INHIBITOR | 2019-07-25 |
20190225601 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2019-07-25 |
20190225602 | Propionic Acid Derivatives and Methods of Use Thereof | 2019-07-25 |
20190225603 | DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2019-07-25 |
20190225604 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | 2019-07-25 |
20190225605 | DEUTERATED PALBOCICLIB | 2019-07-25 |
20190225606 | Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 | 2019-07-25 |
20190225607 | Deuterated Venetoclax | 2019-07-25 |
20190225608 | NOVEL POLYMORPH OF AN INTERMEDIATE FOR PALBOCICLIB SYNTHESIS | 2019-07-25 |
20190225609 | FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF | 2019-07-25 |
20190225610 | DEUTERATED 3-(4,5-SUBSTITUTED AMINOPYRIMIDINE)PHENYL DERIVATIVES AND USE THEREOF | 2019-07-25 |
20190225611 | SUBSTITUTED SPIROCYCLIC INHIBITORS OF AUTOTAXIN | 2019-07-25 |
20190225612 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | 2019-07-25 |
20190225613 | Compounds For Repressing Cancer Cell Growth | 2019-07-25 |
20190225614 | CRYSTALS OF [2-(1-METHYL-1H-PYRAZOL-4-YL)-6(MORPHOLIN-4-YL)-9H-PURIN-8-YL][4-(MORPHOL- IN-4-YL)PIPERIDIN-1-YL]METHANONE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2019-07-25 |
20190225615 | PURINE AND 3-DEAZAPURINE ANALOGUES AS CHOLINE KINASE INHIBITORS | 2019-07-25 |
20190225616 | METHODS OF PREPARING CO-CRYSTALS OF IBRUTINIB WITH CARBOXYLIC ACIDS | 2019-07-25 |
20190225617 | RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | 2019-07-25 |
20190225618 | IDO Inhibitors | 2019-07-25 |
20190225619 | THIOGLYCOLURIL COMPOUND, AND METHOD FOR PRODUCING SAME | 2019-07-25 |
20190225620 | IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES | 2019-07-25 |
20190225621 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | 2019-07-25 |
20190225622 | Process for the Preparation of Oxymorphone Alkaloid and Oxymorphone Salts | 2019-07-25 |
20190225623 | SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF | 2019-07-25 |
20190225624 | INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS | 2019-07-25 |
20190225625 | NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS | 2019-07-25 |
20190225626 | ISOSULFAN BLUE, ITS CRYSTALLINE FORM AND PROCESS FOR PREPARATION THEREOF | 2019-07-25 |
20190225627 | NITROGEN-CONTAINING COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | 2019-07-25 |
20190225628 | BETA-LACTAMASE INHIBITORS | 2019-07-25 |
20190225629 | METHOD FOR PREPARING SILAHYDROCARBONS | 2019-07-25 |
20190225630 | METHOD FOR PRODUCING N-SILYLAMINOALKYLSILANE COMPOUND | 2019-07-25 |
20190225631 | NOVEL DIPHENYLMETHANE PROTECTIVE AGENT | 2019-07-25 |
20190225632 | CYCLIC GERMANIUM COMPOUNDS AND APPLICATIONS THEREOF | 2019-07-25 |
20190225633 | DNA ALKYLATING AGENTS | 2019-07-25 |
20190225634 | NAHLSGEN OPTICAL RESOLUTION METHOD | 2019-07-25 |
20190225635 | METAL COMPLEXES CONTAINING SUBSTITUTED PYRIDINE LIGANDS | 2019-07-25 |
20190225636 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | 2019-07-25 |
20190225637 | PRODUCTION OF BIOMASS IN ULTRA HIGH DENSITY PLANTATIONS | 2019-07-25 |
20190225638 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | 2019-07-25 |
20190225639 | PROCESS FOR THE PREPARATION OF DIOSMIN | 2019-07-25 |
20190225640 | KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | 2019-07-25 |
20190225641 | Crystal Forms of Beta-Nicotinamide Mononucleotide | 2019-07-25 |
20190225642 | CRYSTAL OF CYTIDINE DIPHOSPHATE CHOLINE AND PRODUCTION METHOD THEREOF | 2019-07-25 |
20190225643 | NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT | 2019-07-25 |
20190225644 | MRNA CAP ANALOGS AND METHODS OF MRNA CAPPING | 2019-07-25 |
20190225645 | Method for Preparing a Complete Protein and Uses Thereof | 2019-07-25 |
20190225646 | Method for Purifying Recombinant Protein | 2019-07-25 |
20190225647 | ANTIGENIC PEPTIDES FOR THE DIAGNOSIS, THERAPY MONITORING AND/OR TREATMENT OF PSORIASIS VULGARIS | 2019-07-25 |
20190225648 | BIOLOGICALLY ACTIVE PEPTIDES | 2019-07-25 |
20190225649 | AGENTS THAT ACTIVATE CD47 AND THEIR USE IN THE TREATMENT OF INFLAMMATION | 2019-07-25 |
20190225650 | PEPTIDOMIMETIC MACROCYCLES AND USE THEREOF IN REGULATING HIF1ALPHA | 2019-07-25 |
20190225651 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | 2019-07-25 |
20190225652 | GENERATION OF PEPTIDES | 2019-07-25 |
20190225653 | CAGED CELL PENETRATING PEPTIDE-POLYMER CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | 2019-07-25 |
20190225654 | METHODS AND COMPOSITIONS FOR DENGUE VIRUS VACCINES | 2019-07-25 |
20190225655 | FACTOR H BINDING PROTEIN VARIANTS AND METHODS OF USE THEREOF | 2019-07-25 |
20190225656 | ALPHA-HEMOLYSIN VARIANTS WITH ALTERED CHARACTERISTICS | 2019-07-25 |
20190225657 | METHOD FOR THE PRODUCTION OF HAPLOID AND SUBSEQUENT DOUBLED HAPLOID PLANTS | 2019-07-25 |
20190225658 | PEPTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF TREATING ATRIAL FIBRILLATION | 2019-07-25 |
20190225659 | ODORANT RECEPTOR CO-RECEPTOR | 2019-07-25 |
20190225660 | METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS | 2019-07-25 |
20190225661 | Compositions and Methods for Vascular Protection Against Reperfusion Injury After Myocardial Ischemia | 2019-07-25 |
20190225662 | Therapeutic Agents for Neurological and Psychiatric Disorders | 2019-07-25 |
20190225663 | Discovery of Cationic Nonribosomal Peptides as Gram-Negative Antibiotics Through Global Genome Mining | 2019-07-25 |
20190225664 | ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS | 2019-07-25 |
20190225665 | VARIANT TYPE III INTERFERONS AND SYNTHEKINES | 2019-07-25 |
20190225666 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | 2019-07-25 |
20190225667 | INDUCIBLE CASPASES AND METHODS FOR USE | 2019-07-25 |
20190225668 | HUMAN-CD123-TARGETING CHIMERIC RECEPTOR LIGAND AND APPLICATION THEREOF | 2019-07-25 |
20190225669 | TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF | 2019-07-25 |
20190225670 | COMPOUNDS AND METHODS FOR ACTIVATING TIE2 SIGNALING | 2019-07-25 |
20190225671 | TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES | 2019-07-25 |
20190225672 | TRIPLE VECTOR FOR EXPRESSING ANTIBODY MOLECULES IN FULL THERAPEUTIC FORMAT | 2019-07-25 |
20190225673 | ANTIBODY BASED GENE THERAPY WITH TISSUE-DIRECTED EXPRESSION | 2019-07-25 |
20190225674 | TOOLS FOR NEXT GENERATION KOMAGATAELLA (PICHIA) ENGINEERING | 2019-07-25 |
20190225675 | METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT NEUTRALIZING BINDING PROTEIN | 2019-07-25 |
20190225676 | FUSION PROTEINS FOR OPTHALMOLOGY WITH INCREASED EYE RETENTION | 2019-07-25 |
20190225677 | RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR | 2019-07-25 |
20190225678 | ANTI-C5 ANTIBODY FOR TREATING PATIENTS WITH COMPLEMENT C5 POLYMORPHISM | 2019-07-25 |